NasdaqCM:TGTXBiotechs
TG Therapeutics (TGTX) Tests A Key Moving Average, Is The Stock Fully Priced?
Technical setup takes shape after early August sell off
TG Therapeutics (TGTX) is back in focus after the stock formed a cup style base following a sell off in early August, with shares now testing a key moving average.
This type of technical setup often interests traders who follow price patterns. It can highlight areas where buying and selling pressure may be starting to rebalance after a sharp move.
See our latest analysis for TG Therapeutics.
For context, TG Therapeutics has seen strong...